Late-stage biotech developing a treatment for excess potassium (hyperkalemia).
Industry: Health Care
First Day Return: +57.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/15/2014 |
Offer Price | $18.00 |
Price Range n/a | |
Offer Shares (mm) | 5.9 |
Deal Size ($mm) | $107 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/17/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $107 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Coppell, TX, United States |
Founded | 2008 |
Employees at IPO | 41 |
Website www.zspharma.com |